Cosa pensi dell’ultima intervista di Roche sulla Svizzera meno importante per gli altri Paesi (NZZ)?

After reading the article I feel on one side: Pressed by a big multinational polarizing on the bilateral discussion and immigration – mostly looking after themselves. But at the same time, working in this field I can confirm that other countries are heavily lobbying to get pharma to their countries – which would be a massive loss for us.

Doesn’t it just come down to immigration? Let’s say if Switzerland would put in a high-qualified immigration-only clause and negotiate to keep certain EU bilateral then everybody is happy? At the end everybody looks after themselves: A pharma, a swiss citizen, a immigrant and the EU?